Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
Nature Reviews. Gastroenterology & Hepatology|November 3, 2021
Evolutionary dynamics in Barrett oesophagus: implications for surveillance, risk stratification and therapyMelissa Schmidt, Richard J Hackett, Ann-Marie Baker, et al.
Nature Clinical Practice. Gastroenterology & Hepatology|May 5, 2006
Mechanisms of disease: from stem cells to colorectal cancerStuart A C McDonald, Sean L Preston, Matthew J Lovell, et al.
The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland|August 14, 2008
The role of imaging in the pre-operative staging and post-operative follow-up of rectal cancerG Low, L M Tho, E Leen, et al.
The Journal of Infectious Diseases|August 6, 2004
Protection against the early acute phase of Cryptosporidium parvum infection conferred by interleukin-4-induced expression of T helper 1 cytokinesStuart A C McDonald, John E O'Grady, Mona Bajaj-Elliott, et al.
The Journal of Pathology|May 23, 2013
Crypt dysplasia in Barrett's oesophagus shows clonal identity between crypt and surface cellsShabuddin Khan, Stuart A C McDonald, Nicholas A Wright, et al.
Infection and Immunity|July 23, 2003
Interleukin-4 and transforming growth factor beta have opposing regulatory effects on gamma interferon-mediated inhibition of Cryptosporidium parvum reproductionI-Sarah Lean, Stuart A C McDonald, Mona Bajaj-Elliott, et al.
Journal of Musculoskeletal & Neuronal Interactions|December 20, 2014
Sharpin is a key regulator of skeletal homeostasis in a TNF-dependent mannerH W McGowan, J A Schuijers, B L Grills, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|September 18, 1999
Eighteen-month follow-up of infants fed evaporated milk formulaJ K Friel, W L Andrews, C Edgecombe, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 25, 2007
Combined modality treatment of early rectal cancer: the UK experienceA Sun Myint, R J Grieve, A C McDonald, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2002
A phase I and pharmacokinetic study of capecitabine in combination with epirubicin and cisplatin in patients with inoperable oesophago-gastric adenocarcinomaT R J Evans, G Pentheroudakis, J Paul, et al.
Pageof 8